| Disease | Micro RNA | Tissue/ Cell line | MicroRNA regulation | Pathway | More Details | References |
|---|---|---|---|---|---|---|
| Hepatocellular carcinoma | hsa-miR-338 | Hepatocyte | Hippo signaling pathway | TAZ is involved in the growth of hepatocellular carcinoma cells. Upregulation of miR-338 suppresses the expression of TAZ. | Liu et al., 2015 | |
| Hepatocellular carcinoma | hsa-miR-9 | Hepatocyte | PI3K-Akt signaling pathway | Overexpression of hsa-miR-9 downregulates TAZ expression. Mir-9 promotes HCC cell proliferation through PI3K-Akt signaling pathway. | Higashi et al., 2015 | |
| Hepatocellular carcinoma | hsa-miR-9 | Hepatocyte | ERK pathway | Overexpression of hsa-miR-9 downregulates TAZ expression. Mir-9 promotes HCC cell proliferation through ERK pathway. | Higashi et al., 2015 | |
| Hepatocellular carcinoma | hsa-miR-9 | Hepatocyte | Beta-catenin pathway | Overexpression of hsa-miR-9 downregulates TAZ expression. Mir-9 promotes HCC cell proliferation through Beta-catenin pathway. | Higashi et al., 2015 |